Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 20.

Zingg, Daniel; Debbache, Julien; Peña-Hernández, Rodrigo; Antunes, Ana T; Schaefer, Simon M; Cheng, Phil F; Zimmerli, Dario; Haeusel, Jessica; Calçada, Raquel R; Tuncer, Eylul; Zhang, Yudong; Bossart, Raphaël; Wong, Kwok-Kin; Basler, Konrad; Dummer, Reinhard; Santoro, Raffaella; Levesque, Mitchell P; Sommer, Lukas (2018). EZH2-mediated primary cilium deconstruction drives metastatic melanoma formation. Cancer Cell, 34(1):69-84.

Brüggen, Marie-Charlotte; Mangana, Joanna; Irmisch, Anja; French, Lars E; Levesque, Mitchell P; Cheng, Phil F; Dummer, Reinhard (2018). Methadone - not a magic bullet in melanoma therapy. Experimental Dermatology, 27(6):694-696.

Krähenbühl, Lukas; Goldinger, Simone M; Mangana, Joanna; Kerl, Katrin; Chevolet, Ines; Brochez, Liève; Horak, Christine; Levesque, Mitch; Dummer, Reinhard; Cheng, Phil F (2018). A Longitudinal Analysis of IDO and PDL1 Expression during Immune- or Targeted Therapy in Advanced Melanoma. Neoplasia, 20(2):218-225.

Silina, Karina; Soltermann, Alex; Movahedian Attar, Farkhondeh; Casanova, Ruben; Uckeley, Zina M; Thut, Helen; Wandres, Muriel; Isajevs, Sergejs; Cheng, Phil F; Curioni Fontecedro, Alessandra; Foukas, Periklis; Levesque, Mitchell P; Moch, Holger; Linē, Aija; van den Broek, Maries (2018). Germinal centers determine the prognostic relevance of tertiary lymphoid structures and are impaired by corticosteroids in lung squamous cell carcinoma. Cancer Research, 78(5):1308-1320.

Hogan, Sabrina A; Levesque, Mitchell P; Cheng, Phil F (2018). Melanoma Immunotherapy: Next-Generation Biomarkers. Frontiers in Oncology:8:178.

Zila, Nina; Bileck, Andrea; Muqaku, Besnik; Janker, Lukas; Eichhoff, Ossia M; Cheng, Phil F; Dummer, Reinhard; Levesque, Mitchell P; Gerner, Christopher; Paulitschke, Verena (2018). Proteomics-based insights into mitogen-activated protein kinase inhibitor resistance of cerebral melanoma metastases. Clinical Proteomics, 15:13.

Restivo, Gaetana; Diener, Johanna; Cheng, Phil F; Kiowski, Gregor; Bonalli, Mario; Biedermann, Thomas; Reichmann, Ernst; Levesque, Mitchell P; Dummer, Reinhard; Sommer, Lukas (2017). The low affinity neurotrophin receptor CD271 regulates phenotype switching in melanoma. Nature Communications, 8(1):1988.

Mangana, Joanna; Cheng, Phil F; Kaufmann, Corina; Amann, Valerie C; Frauchiger, Anna L; Stögner, Viola; Held, Ulrike; von Moos, Roger; Michielin, Olivier; Braun, Ralph P; Levesque, Mitchell P; Goldinger, Simone M; Dummer, Reinhard (2017). Multicenter, real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in Switzerland. Melanoma research, 27(4):358-368.

Haueis, Silvia A; Kränzlin, Pascale; Mangana, Joanna; Cheng, Phil F; Urosevic-Maiwald, Mirjana; Braun, Ralph P; Levesque, Mitchell P; Dummer, Reinhard; Goldinger, Simone M (2017). Does the distribution pattern of brain metastases during BRAF inhibitor therapy reflect phenotype switching? Melanoma research, 27(3):231-237.

Behera, Reeti; Kaur, Amanpreet; Webster, Marie R; Kim, Suyeon; Ndoye, Abibatou; Kugel, Curtis H; Alicea, Gretchen M; Wang, Joshua X; Ghosh, Kanad; Cheng, Phil F; Lisanti, Sofia; Marchbank, Katie; Dang, Vanessa; Levesque, Mitchell Paul; Dummer, Reinhard; Xu, Xiaowei; Heryn, Meenhard; Aplin, Andrew E; Roesch, Alexander; Caino, M. Cecilia; Altieri, Dario C; Weeraratna, Ashani T (2017). Inhibition of age-related therapy resistance in melanoma by rosiglitazone-mediated induction of Klotho. Clinical Cancer Research, 23(12):3181-3190.

Levesque, Mitchell P; Cheng, Phil F; Raaijmakers, Marieke I G; Saltari, Annalisa; Dummer, Reinhard (2017). Metastatic melanoma moves on: translational science in the era of personalized medicine. Cancer Metastasis Reviews, 36(1):7-21.

Raaijmakers, Marieke I G; Widmer, Daniel S; Narechania, Apurva; Eichhoff, Ossia; Freiberger, Sandra N; Wenzina, Judith; Cheng, Phil F; Mihic-Probst, Daniela; Desalle, Rob; Dummer, Reinhard; Levesque, Mitchell P (2016). Co-existence of BRAF and NRAS driver mutations in the same melanoma cells results in heterogeneity of targeted therapy resistance. OncoTarget, 7(47):77163-77174.

Rozati, Sima; Cheng, Phil F; Widmer, Daniel S; Fujii, Kazuyasu; Levesque, Mitchell Paul; Dummer, Reinhard (2016). Romidepsin and azacitidine synergize in their epigenetic modulatory effects to induce apoptosis in CTCL. Clinical Cancer Research, 22(8):2020-2031.

Freiberger, Sandra N; Cheng, Phil F; Iotzova-Weiss, Guergana; Neu, Johannes; Liu, Qinxiu; Dziunycz, Piotr; Zibert, John R; Dummer, Reinhard; Skak, Kresten; Levesque, Mitchell P; Hofbauer, Günther F L (2015). Ingenol mebutate signals via PKC/MEK/ERK in keratinocytes and induces interleukin decoy receptors IL1R2 and IL13RA2. Molecular Cancer Therapeutics, 14(9):2132-2142.

Urosevic-Maiwald, Mirjana; Barysch, Marjam J; Cheng, Phil F; Karpova, Maria B; Steinert, Hans; Okoniewski, Michal J; Dummer, Reinhard (2015). In vivo profiling reveals immunomodulatory effects of sorafenib and dacarbazine on melanoma. OncoImmunology, 4(2):e988458.

Otsuka, Atsushi; Dreier, Jil; Cheng, Phil F; Nägeli, Mirjam; Lehmann, Holger; Felderer, Lea; Frew, Ian J; Matsushita, Shigeto; Levesque, Mitchell P; Dummer, Reinhard (2015). Hedgehog Pathway Inhibitors Promote Adaptive Immune Responses in Basal Cell Carcinoma. Clinical Cancer Research:1289-1297.

Mangana, Joanna; Cheng, Phil F; Schindler, Katja; Weide, Benjamin; Held, Ulrike; Frauchiger, Anna L; Romano, Emanuella; Kähler, Katharina C; Rozati, Sima; Rechsteiner, Markus; Moch, Holger; Michielin, Olivier; Garbe, Claus; Hauschild, Axel; Hoeller, Christoph; Dummer, Reinhard; Goldinger, Simone M (2015). Analysis of BRAF and NRAS mutation status in advanced melanoma patients treated with anti-CTLA-4 antibodies: association with overall survival? PLoS ONE, 10(10):e0139438.

Cheng, Phil F; Dummer, Reinhard; Levesque, Mitchell P (2015). Data mining the cancer genome atlas in the era of precision cancer medicine. Swiss Medical Weekly, 145:w14183.

Cheng, Phil F; Shakhova, Olga; Widmer, Daniel S; Eichhoff, Ossia M; Zingg, Daniel; Frommel, Sandra C; Belloni, Benedetta; Raaijmakers, Marieke Ig; Goldinger, Simone M; Santoro, Raffaella; Hemmi, Silvio; Sommer, Lukas; Dummer, Reinhard; Levesque, Mitchell P (2015). Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma. Genome Biology, 16:42.

Widmer, Daniel S; Hoek, Keith S; Cheng, Phil F; Eichhoff, Ossia M; Biedermann, Thomas; Raaijmakers, Marieke I G; Hemmi, Silvio; Dummer, Reinhard; Levesque, Mitchell P (2013). Hypoxia contributes to melanoma heterogeneity by triggering HIF1α-dependent phenotype switching. Journal of Investigative Dermatology, 133(10):2436-2443.

This list was generated on Tue Aug 21 22:33:57 2018 CEST.